165 related articles for article (PubMed ID: 26872010)
1. Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation.
Busam KJ; Vilain RE; Lum T; Busam JA; Hollmann TJ; Saw RP; Coit DC; Scolyer RA; Wiesner T
Am J Surg Pathol; 2016 Jun; 40(6):786-95. PubMed ID: 26872010
[TBL] [Abstract][Full Text] [Related]
2. Primary and Metastatic Melanoma With NTRK Fusions.
Lezcano C; Shoushtari AN; Ariyan C; Hollmann TJ; Busam KJ
Am J Surg Pathol; 2018 Aug; 42(8):1052-1058. PubMed ID: 29683819
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of BAP1, ROS1, and ALK in Spitzoid Melanocytic Tumors.
Cardili L; Viana CR; Germano A; Fernandes M; Barcellos D; Landman G
Int J Surg Pathol; 2018 Sep; 26(6):514-520. PubMed ID: 29623743
[TBL] [Abstract][Full Text] [Related]
5. Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
Niu HT; Zhou QM; Wang F; Shao Q; Guan YX; Wen XZ; Chen LZ; Feng QS; Li W; Zeng YX; Zhang XS
Pigment Cell Melanoma Res; 2013 Sep; 26(5):646-53. PubMed ID: 23751074
[TBL] [Abstract][Full Text] [Related]
6. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
7. The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors.
Ronchi A; Montella M; Cozzolino I; Argenziano G; Moscarella E; Piccolo V; Iovino F; Troiani T; Alfano R; Errico ME; D'Onofrio V; Berretta M; Franco R; Zito Marino F
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3829-3838. PubMed ID: 32329859
[TBL] [Abstract][Full Text] [Related]
8. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
9. A case report of atypical Spitz tumor harboring a novel MLPH-ALK gene fusion with discordant ALK immunohistochemistry results.
Fujimoto M; Togashi Y; Matsuzaki I; Baba S; Takeuchi K; Inaba Y; Jinnin M; Murata SI
Hum Pathol; 2018 Oct; 80():99-103. PubMed ID: 29514107
[TBL] [Abstract][Full Text] [Related]
10. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
11. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
12. Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK).
Perkins IU; Tan SY; McCalmont TH; Chou PM; Mully TW; Gerami P; Pomerantz JH; Reyes-Múgica M; Balkin DM; Kruse LL; Huang B; Reichek JL; Gangopadhyay N; Chiosea S; Green JR; Chamlin SL; Frieden IJ; Bastian BC; Yeh I
Pigment Cell Melanoma Res; 2024 Jan; 37(1):6-14. PubMed ID: 37475109
[TBL] [Abstract][Full Text] [Related]
13. Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule.
Xue D; Li X; Ren Y; Liu Q; Yen Y; Xue L
Int J Surg Pathol; 2015 Jun; 23(4):333-5. PubMed ID: 25633507
[TBL] [Abstract][Full Text] [Related]
14. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.
Ashida A; Takata M; Murata H; Kido K; Saida T
Int J Cancer; 2009 Feb; 124(4):862-8. PubMed ID: 19035443
[TBL] [Abstract][Full Text] [Related]
15. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
[TBL] [Abstract][Full Text] [Related]
16. [Morphological and genetic aspects of Spitz tumors].
Wiesner T; Kutzner H
Pathologe; 2015 Feb; 36(1):37-43, 45. PubMed ID: 25613920
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
[TBL] [Abstract][Full Text] [Related]
18. Spitz Tumors: Comparison of Histological Features in Relationship to Immunohistochemical Staining for ALK and NTRK1.
Kiuru M; Jungbluth A; Kutzner H; Wiesner T; Busam KJ
Int J Surg Pathol; 2016 May; 24(3):200-6. PubMed ID: 26873340
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
20. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential.
Wu H; Barusevicius A; Babb J; Klein-Szanto A; Godwin A; Elenitsas R; Gelfand JM; Lessin S; Seykora JT
J Cutan Pathol; 2005 Feb; 32(2):125-30. PubMed ID: 15606670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
